Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Depsipeptide in Advanced Malignant Melanoma
NCT00104884Phase 2Terminated
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Start
- Oct 2005
- Primary completion
- May 2006
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of romidepsin in Malignant Melanoma (MM), sponsored by ECOG-ACRIN Cancer Research Group. Started Oct 2005; status: terminated.
02
Drugs
romidepsin
03
Conditions
Malignant Melanoma (MM)
Beyond the preview
Go deeper on NCT00104884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00104884.